Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' EQUITY (Tables)

v3.22.1
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2021
STOCKHOLDERS' EQUITY  
Schedule of stock based compensation expense related to stock options and common stock

    

For the Years Ended

December 31, 

    

2021

    

2020

Sales and marketing

$

270,460

$

54,723

Technology

 

31,631

 

13,891

General and administrative

 

421,951

 

399,602

Total

$

724,042

$

468,216

Summary of Black-Scholes Pricing Model Stock Options

    

For the Years Ended

 

December 31, 

 

 

2021

    

2020

Expected term (years)

 

N/A

6.08

Expected volatility

 

N/A

55.8%-56.3%

Risk free interest rate

 

N/A

0.57%-1.65%

Expected dividends

 

N/A

0.00%

Summary of stock option activity

A summary of the Company’s stock option activity during the year ended December 31, 2021 is as follows:

    

    

    

Weighted Average

    

Number

Weighted Average

Remaining Term 

Intrinsic

    

of Options

    

Exercise Price

    

(Years)

    

Value

Outstanding at January 1,2021

 

118,412

$

15.22

 

  

 

  

Granted

 

 

 

  

 

  

Forfeited

 

(21,150)

 

33.16

 

  

 

  

Exercised

 

(2,815)

 

2.97

 

  

 

  

Outstanding at December 31, 2021

 

94,447

$

11.56

 

4.4

$

6,339

Exercisable at December 31, 2021

 

66,240

$

9.49

 

2.9

$

3,276

Summary of stock option exercise price

The following table presents information related to stock options as of December 31, 2021:

Options Outstanding

    

Options Exercisable

Weighted

Outstanding

Average

Exercisable

Number of

Remaining Life

Number of

Exercise Price

    

Options

    

In Years

    

Options

$

2.81

 

20,000

 

8.9

 

5,416

$

2.97

 

42,779

 

0.7

 

42,779

$

4.95

 

5,556

 

0.9

 

4,255

$

33.75

 

26,112

 

7.8

 

13,790

 

94,447

 

2.9

 

66,240

Summary of assumptions fair value of warrants

    

For the Years Ended

 

December 31, 

 

2021

    

2020

 

Expected term (years)

 

N/A

3.86-4.75

Expected volatility

 

N/A

58.0%-61.2%

Risk free interest rate

 

N/A

0.24%-0.39%

Expected dividends

 

N/A

0.00%

Summary of the warrant activity

    

    

    

    

Weighted

    

    

Weighted

Average

Average

Remaining

Number of

Exercise

Life

Intrinsic

    

Warrants

    

Price

    

In Years

    

Value

Outstanding, January 1, 2021

 

6,167,745

$

5.26

 

  

 

  

Issued

 

867,286

 

5.50

 

  

 

  

Exercised

 

(2,281,668)

 

5.04

 

  

 

  

Expired

 

 

 

  

 

  

Outstanding, December 31, 2021[1]

 

4,753,363

$

5.42

 

3.5

$

Exercisable, December 31, 2021

 

4,753,363

$

5.35

 

3.5

$

[1] Excludes five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share that are issuable upon exercise of certain warrants.

Summary of stock warrants

The following table presents information related to stock warrants as of December 31, 2021:

Warrants Outstanding

    

Warrants Exercisable

Weighted

Outstanding

Average

Exercisable

Number of

Remaining Life

Number of

Exercise Price

Warrants

In Years

    

Warrants

$

4.20

 

368,711

 

2.7

 

368,711

$

4.95

 

177,223

 

1.3

 

177,223

$

5.50

 

3,998,459

 

3.7

 

3,998,459

$

6.25

 

32,500

 

3.6

 

32,500

$

6.38

 

176,470

 

4.0

 

176,470

 

4,753,363

 

3.5

 

4,753,363